DLC1 and Liver Cancer: The Akt Connection

被引：3
|
作者：
Wuestefeld, Torsten
Zender, Lars [1 ]
机构：
[1] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany
来源：
GASTROENTEROLOGY | 2010年 / 139卷 / 04期
关键词：
HUMAN HEPATOCELLULAR-CARCINOMA; GTPASE-ACTIVATING PROTEIN; SUPPRESSOR GENE DLC1; TUMOR-SUPPRESSOR; ABERRANT METHYLATION; PROSTATE-CANCER; CELL; 8P22; EXPRESSION; PROGNOSIS;
D O I：
10.1053/j.gastro.2010.08.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1093 / 1096
页数：5
相关论文
共 50 条
  • [21] Regulation of white and brown adipocyte differentiation by RhoGAP DLC1
    Simi, Choon Kiat
    Kim, Sun-Yee
    Brunmeir, Reinhard
    Zhang, Qiongyi
    Li, Hongyu
    Dharmasegaran, Dharmini
    Leong, Carol
    Lim, Ying Yan
    Han, Weiping
    Xu, Feng
    PLOS ONE, 2017, 12 (03):
  • [22] Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
    Bujko, M.
    Kober, P.
    Rusetska, N.
    Wakua, M.
    Goryca, K.
    Grecka, E.
    Matyja, E.
    Neska, J.
    Mandat, T.
    Bonicki, W.
    Siedlecki, J. A.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 473 - 484
  • [23] Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application
    Ren, Guanghui
    Li, Guorong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 182 : 264 - 275
  • [24] Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study
    Zheng, SQL
    Mychaleckyj, JC
    Hawkins, GA
    Isaacs, SD
    Wiley, KE
    Turner, A
    Chang, BL
    von Kap-Herr, C
    Carpten, JD
    Pettenati, M
    Bleecker, ER
    Walsh, PC
    Trent, JM
    Meyers, DA
    Isaacs, WB
    Xu, JF
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 528 (1-2) : 45 - 53
  • [25] Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
    Su, Yuqi
    Lin, Li
    Zhang, Jingwen
    Jiang, Yaqi
    Pan, Changqie
    Sun, Li
    Duan, Jiangman
    Liao, Wangjun
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 5771 - 5779
  • [26] MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1
    Zhang, Guang-jun
    Li, Jian-shui
    Zhou, He
    Xiao, Hua-xu
    Li, Yu
    Zhou, Tong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [27] Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells
    Zhu, Wenzhen
    Ma, Long
    Yang, Bingwu
    Zheng, Zhaodi
    Chai, Rongfei
    Liu, Tingting
    Liu, Zhaojun
    Song, Taiyu
    Li, Fenglin
    Li, Guorong
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2016, 52 (05) : 589 - 597
  • [28] GAP-independent functions of DLC1 in metastasis
    Barras, David
    Widmann, Christian
    CANCER AND METASTASIS REVIEWS, 2014, 33 (01) : 87 - 100
  • [29] The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
    Li, Yao
    Meng, Xue
    Luo, Yuqing
    Luo, Shuai
    Li, Jin
    Zeng, Jiafei
    Huang, Xiang
    Wang, Jinjing
    AGING-US, 2023, 15 (18): : 9809 - 9821
  • [30] Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis
    Ko, Frankie Chi Fat
    Chan, Lo-Kong
    Tung, Edmund Kwok-Kwan
    Lowe, Scott W.
    Ng, Irene Oi-Lin
    Yam, Judy Wai Ping
    GASTROENTEROLOGY, 2010, 139 (04) : 1397 - +
12345